| scholarly article | Q13442814 |
| P50 | author | Ann Reynolds | Q58144186 |
| P2093 | author name string | L Li | |
| L Zhang | |||
| E Berry-Kravis | |||
| F Tassone | |||
| J Grigsby | |||
| L Gane | |||
| P J Hagerman | |||
| R J Hagerman | |||
| S Jacquemont | |||
| C G Goetz | |||
| D A Hall | |||
| C D Rice | |||
| R Lara | |||
| J Cogswell | |||
| M A Leehey | |||
| P2860 | cites work | Evidence for, and a spectrum of, neurological involvement in carriers of the fragile X pre-mutation: FXTAS and beyond | Q48942951 |
| Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1. | Q50277634 | ||
| Impairment in the cognitive functioning of men with fragile X-associated tremor/ataxia syndrome (FXTAS). | Q50278350 | ||
| Magnetic resonance imaging study in older fragile X premutation male carriers | Q50279671 | ||
| Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS). | Q50279685 | ||
| FMR1 premutations associated with fragile X-associated tremor/ataxia syndrome in multiple system atrophy | Q50279964 | ||
| FMR1 gene premutation is a frequent genetic cause of late-onset sporadic cerebellar ataxia. | Q50282467 | ||
| Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation | Q50282509 | ||
| The fragile X premutation presenting as postprandial hypotension | Q50282561 | ||
| A neuropsychological investigation of male premutation carriers of fragile X syndrome | Q50282888 | ||
| Neuropathic features in fragile X premutation carriers. | Q51909237 | ||
| FMR1 premutation as a rare cause of late onset ataxia--evidence for FXTAS in female carriers. | Q51934788 | ||
| Unified Huntington's disease rating scale: Reliability and consistency | Q57422462 | ||
| International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome | Q61925541 | ||
| Tremor and ataxia in fragile X premutation carriers: Blinded videotape study | Q73351650 | ||
| Tests of stepping as indicators of mobility, balance, and fall risk in balance-impaired older adults | Q80226422 | ||
| Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation | Q24533431 | ||
| The Measurement of Observer Agreement for Categorical Data | Q26778373 | ||
| Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population | Q28241139 | ||
| Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome | Q28273791 | ||
| Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates | Q33905067 | ||
| Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. | Q34146206 | ||
| Size bias of fragile X premutation alleles in late-onset movement disorders. | Q36927093 | ||
| Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome | Q43073775 | ||
| Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome | Q43626884 | ||
| FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS). | Q45976696 | ||
| Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). | Q46007399 | ||
| CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS). | Q46218699 | ||
| Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation | Q46224818 | ||
| Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. | Q46601293 | ||
| Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. | Q46666276 | ||
| Obstetrical and gynecological complications in fragile X carriers: a multicenter study | Q46923729 | ||
| Tremor, ataxia and dementia in older men may indicate a carrier of the fragile X syndrome | Q48288503 | ||
| Progression of tremor and ataxia in male carriers of the FMR1 premutation | Q48354732 | ||
| P433 | issue | 16 Pt 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1397-1402 | |
| P577 | publication date | 2007-12-05 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | FMR1 CGG repeat length predicts motor dysfunction in premutation carriers | |
| P478 | volume | 70 |
| Q64865906 | Q64865906 |
| Q35559347 | A cross-sectional analysis of orienting of visuospatial attention in child and adult carriers of the fragile X premutation |
| Q40715457 | A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population |
| Q37460812 | A methylation PCR method determines FMR1 activation ratios and differentiates premutation allele mosaicism in carrier siblings |
| Q37415441 | A novel methylation PCR that offers standardized determination of FMR1 methylation and CGG repeat length without southern blot analysis |
| Q48621332 | ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics |
| Q35047721 | Abnormal dendrite and spine morphology in primary visual cortex in the CGG knock-in mouse model of the fragile X premutation |
| Q37580522 | Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome |
| Q52661580 | Age-related functional brain changes in FMR1 premutation carriers. |
| Q34000722 | Associated features in females with an FMR1 premutation |
| Q88028146 | Association between macroorchidism and intelligence in FMR1 premutation carriers |
| Q42068973 | CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome |
| Q37021134 | CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile X-associated tremor/ataxia syndrome. |
| Q35809701 | Capturing the fragile X premutation phenotypes: a collaborative effort across multiple cohorts |
| Q47999570 | Carriage of One or Two FMR1 Premutation Alleles Seems to Have No Effect on Illness Severity in a FXTAS Female with an Autozygous FMR1 Premutation Allele. |
| Q36483349 | Carriers of the fragile X mental retardation 1 (FMR1) premutation allele present with increased levels of cytokine IL-10. |
| Q50245493 | Characterization and Early Detection of Balance Deficits in Fragile X Premutation Carriers With and Without Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS). |
| Q92152292 | Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale |
| Q91648121 | Cognitive function impacts gait, functional mobility and falls in fragile X-associated tremor/ataxia syndrome |
| Q91835435 | Complexity based measures of postural stability provide novel evidence of functional decline in fragile X premutation carriers |
| Q34983498 | Current research, diagnosis, and treatment of fragile X-associated tremor/ataxia syndrome |
| Q37394408 | Developmental profiles of infants with an FMR1 premutation |
| Q61806814 | Early Identification of Fragile X Syndrome through Expanded Newborn Screening |
| Q37223278 | Ectopic expression of CGG containing mRNA is neurotoxic in mammals |
| Q34077088 | Emerging topics in FXTAS. |
| Q33649463 | Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome |
| Q34231104 | Eye movements reveal impaired inhibitory control in adult male fragile X premutation carriers asymptomatic for FXTAS. |
| Q37601806 | FMR1 gray-zone alleles: association with Parkinson's disease in women? |
| Q37216636 | FMR1: a gene with three faces |
| Q39933003 | Family Communication and Cascade Testing for Fragile X Syndrome |
| Q38851924 | Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) Motor Dysfunction Modeled in Mice |
| Q38880460 | Fragile X-associated tremor/ataxia syndrome: another phenotype of the fragile X gene |
| Q33477846 | Fragile X-associated tremor/ataxia syndrome: clinical phenotype, diagnosis, and treatment |
| Q38896237 | Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders |
| Q34329664 | Fragile x-associated tremor ataxia syndrome: the expanding clinical picture, pathophysiology, epidemiology, and update on treatment |
| Q56971626 | Fragiles X-assoziiertes Tremor-/Ataxie-Syndrom |
| Q50244394 | Gait and Functional Mobility Deficits in Fragile X-Associated Tremor/Ataxia Syndrome |
| Q35125117 | Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome |
| Q55007011 | Health Profiles of Mosaic Versus Non-mosaic FMR1 Premutation Carrier Mothers of Children With Fragile X Syndrome. |
| Q36006297 | High rates of parkinsonism in adults with autism |
| Q55665860 | Immune mediated disorders in women with a fragile X expansion and FXTAS. |
| Q37564195 | Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models |
| Q46708960 | Impaired response inhibition is associated with self-reported symptoms of depression, anxiety, and ADHD in female FMR1 premutation carriers. |
| Q40080863 | Implications of the FMR1 Premutation for Children, Adolescents, Adults, and Their Families |
| Q92203559 | Language processing skills linked to FMR1 variation: A study of gaze-language coordination during rapid automatized naming among women with the FMR1 premutation |
| Q55516344 | Middle Cerebellar Peduncle Width—A Novel MRI Biomarker for FXTAS? |
| Q28077980 | Molecular Correlates and Recent Advancements in the Diagnosis and Screening of FMR1-Related Disorders |
| Q37455479 | Molecular pathogenesis of fragile X-associated tremor/ataxia syndrome |
| Q35037764 | Mouse models of the fragile x premutation and the fragile X associated tremor/ataxia syndrome |
| Q36882908 | Neurological and endocrine phenotypes of fragile X carrier women |
| Q37154956 | New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS) |
| Q34359862 | New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype. |
| Q35537475 | Novel methylation markers of the dysexecutive-psychiatric phenotype in FMR1 premutation women |
| Q89695595 | Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS) |
| Q40512900 | Parkinsonism and cognitive decline in a fragile X mosaic male |
| Q37199782 | Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease |
| Q33604446 | Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited |
| Q48324319 | Preliminary evidence of an effect of cerebellar volume on postural sway in FMR1 premutation males. |
| Q34399389 | Premutation CGG-repeat expansion of the Fmr1 gene impairs mouse neocortical development. |
| Q30454136 | Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome |
| Q38847227 | Prevalence and predictors of subjective memory complaints in adult male carriers of the FMR1 premutation |
| Q33846889 | Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers. |
| Q26992035 | RNA-mediated neurodegeneration in fragile X-associated tremor/ataxia syndrome |
| Q37399680 | RNA-mediated pathogenesis in fragile X-associated disorders |
| Q33775794 | Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome |
| Q36474429 | Regulatory RNAs in brain function and disorders |
| Q48433730 | Relevance of corpus callosum splenium versus middle cerebellar peduncle hyperintensity for FXTAS diagnosis in clinical practice |
| Q27011565 | Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders |
| Q40117267 | Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients |
| Q61446016 | Static and dynamic postural control deficits in aging fragile X mental retardation 1 (FMR1) gene premutation carriers |
| Q35053183 | Temporal dynamics of attentional selection in adult male carriers of the fragile X premutation allele and adult controls |
| Q92582662 | The Corpus Callosum Splenium Sign in Fragile X-Associated Tremor Ataxia Syndrome |
| Q59329392 | The Spectrum of Neurological and White Matter Changes and Premutation Status Categories of Older Male Carriers of the Alleles Are Linked to Genetic (CGG and FMR1 mRNA) and Cellular Stress (AMPK) Markers |
| Q37803583 | The behavioral phenotype of FMR1 mutations |
| Q34055459 | The cognitive neuropsychological phenotype of carriers of the FMR1 premutation. |
| Q30249226 | The fragile X mental retardation 1 gene (FMR1): historical perspective, phenotypes, mechanism, pathology, and epidemiology |
| Q37806971 | The fragile x-associated tremor and ataxia syndrome (FXTAS) |
| Q26852891 | The multiple molecular facets of fragile X-associated tremor/ataxia syndrome |
| Q26996649 | Unstable mutations in the FMR1 gene and the phenotypes |
| Q46017473 | Update on the Clinical, Radiographic, and Neurobehavioral Manifestations in FXTAS and FMR1 Premutation Carriers. |
| Q53799975 | Women who carry a fragile X premutation are biologically older than noncarriers as measured by telomere length. |
| Q36757091 | X-inactivation in the clinical phenotype of fragile X premutation carrier sisters |
| Q34630352 | Young adult female fragile X premutation carriers show age- and genetically-modulated cognitive impairments |
| Q91918711 | [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment] |
| Q57174443 | splice variant: A predictor of fragile X-associated tremor/ataxia syndrome |
| Q52374187 | β-glucuronidase use as a single internal control gene may confound analysis in FMR1 mRNA toxicity studies. |
Search more.